HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Retinal vascular calibers and risk of late-life depression: The Rotterdam Study.

AbstractOBJECTIVES:
To test the "vascular depression" hypothesis, the authors investigated whether smaller retinal arteriolar or larger venular calibers, which are markers of cerebral microvascular disease, were associated with incident late-life depression.
METHODS:
The authors included 3,605 participants (age > or =55 years) from the population-based Rotterdam Study with no depression at baseline (1993-1995) and fundus photographs gradable for retinal vascular caliber measurements. The authors identified persons with incident depressive symptoms and syndromes using psychiatric interviews during follow-up visits and continuous monitoring. The follow-up was complete until October 2005.
RESULTS:
After a mean follow-up of 9.0 years, 555 participants developed incident depression, including 312 with depressive syndrome. Neither smaller arteriolar (age- and sex-adjusted hazard ratio: 1.01; 95% confidence interval: 0.93-1.10), nor larger venular calibers (hazard ratio: 1.02; 95% confidence interval: 0.94-1.12) were associated with incident depressive syndromes.
CONCLUSIONS:
Our data showed no evidence of an association between retinal vascular calibers and incident late-life depression.
AuthorsM Kamran Ikram, Hendrika J Luijendijk, Albert Hofman, Paulus T V M de Jong, Monique M B Breteler, Johannes R Vingerling, Henning Tiemeier
JournalThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry (Am J Geriatr Psychiatry) Vol. 18 Issue 5 Pg. 452-5 (May 2010) ISSN: 1545-7214 [Electronic] England
PMID20429085 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Age Factors
  • Aged
  • Cerebrovascular Disorders (complications, pathology)
  • Depression (complications)
  • Female
  • Humans
  • Netherlands
  • Prospective Studies
  • Retinal Vessels (pathology)
  • Risk Factors
  • Sex Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: